Novabay Pharmaceuticals Share Price (NYSE: NBY)
$1.8
▲
0.15
(9.09%)
Last updated on
Check the interactive Novabay Pharmaceuticals Stock chart to analyse performance
Novabay Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.66Today's High:$2.11
7.78%
Downside
Day's Volatility :21.33%
Upside
14.69%
- 52 Weeks Low:$0.4452 Weeks High:$2.12
75.56%
Downside
52 Weeks Volatility :79.25%
Upside
15.09%
Novabay Pharmaceuticals Stock Returns
Novabay Pharmaceuticals Inc Key Stats
Check Novabay Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Novabay Pharmaceuticals Stock including INR - Dollar returns
The Novabay Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novabay Pharmaceuticals investment value today
Current value as on today
₹3,80,284
Returns
₹2,80,284
(+280.28%)
Returns from Novabay Pharmaceuticals Stock
₹2,75,000 (+275%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Novabay Pharmaceuticals Stock
Analyst Recommendation on Novabay Pharmaceuticals Stock
Buy
83%Buy
16%Hold
0%Sell
Based on 6 Wall street analysts offering stock ratings for Novabay Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Novabay Pharmaceuticals Share Price Target
What analysts predicted
Downside of 52.78%
Target:
$0.85
Current:
$1.80
Novabay Pharmaceuticals share price target is $0.85, a slight Downside of 52.78% compared to current price of $1.80 as per analysts' prediction.
Novabay Pharmaceuticals Stock Insights
Price Movement
In the last 7 days, NBY stock has moved up by 99.4%Decreasing Revenue
Revenue is down for the last 3 quarters, 2.44M → 2.30M (in $), with an average decrease of 2.7% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, 7.67M → -1.92M (in $), with an average decrease of 125.1% per quarterNBY vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 211.9%
Novabay Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Novabay Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Novabay Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 205.81% | 212.55% | 274.54% | -99.35% | -99.83% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.67 | 0.67 | 0.0 | 0.0 | -4.14 | -0.65 | NA | 0.73 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $9.6M | -99.83% | 0.67 | 33.98% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Novabay Pharmaceuticals Inc
Key Management of Novabay Pharmaceuticals Inc
Important FAQs about investing in NBY Stock from India :
What is Novabay Pharmaceuticals share price today?
Novabay Pharmaceuticals share price today is $1.80 as on at the close of the market. Novabay Pharmaceuticals share today touched a day high of $2.11 and a low of $1.66.
What is the 52 week high and 52 week low for Novabay Pharmaceuticals share?
Novabay Pharmaceuticals share touched a 52 week high of $2.12 and a 52 week low of $0.44. Novabay Pharmaceuticals stock price today i.e. is closed at $1.80, lower by 15.09% versus the 52 week high.
How to invest in Novabay Pharmaceuticals Stock (NBY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Novabay Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novabay Pharmaceuticals Shares that will get you 0.8333 shares as per Novabay Pharmaceuticals share price of $1.80 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Novabay Pharmaceuticals Stock (NBY) from India?
Indian investors can start investing in Novabay Pharmaceuticals (NBY) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Novabay Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Novabay Pharmaceuticals share’s latest price of $1.80 as on August 30, 2025 at 1:29 am IST, you will get 5.5556 shares of Novabay Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Novabay Pharmaceuticals has given to Indian investors in the last 5 years?
Novabay Pharmaceuticals stock has given -99.83% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%